Tetanus-Diphtheria booster

BIOLOGICAL2 trials

Sponsors

Eric Thompson, M.D., PT Bio Farma

Conditions

GlioblastomaGlioblastoma MultiformeHuman Papillomavirus (HPV) Infection

Phase 1

Peptide Targets for Glioblastoma Against Novel Cytomegalovirus Antigens

TerminatedNCT02864368

Eric Thompson, M.D.Glioblastoma, Glioblastoma Multiforme

Start: 2016-12-07End: 2020-06-15Updated: 2022-06-09

Phase 3

Immunogenicity and Safety of HPV-4 Vaccine With or Without Td Vaccine in Children

Not yet recruitingNCT07824310

PT Bio FarmaHuman Papillomavirus (HPV) Infection

Start: 2026-10-01End: 2027-01-31Target: 266Updated: 2026-09-17

Related Papers

CTIM-21. PEPTIDE VACCINE DIRECTED TO CMV pp65 FOR TREATMENT OF RECURRENT MALIGNANT GLIOMA AND MEDULLOBLASTOMA IN CHILDREN AND YOUNG ADULTS: PRELIMINARY RESULTS OF A PHASE I TRIAL

Neuro-Oncology2020-11-016 citations